SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

When the NIH canceled grants in March related to diversity, equity and inclusion, or DEI, some Alzheimer’s studies were swept ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to ...

Not surprisingly, finding the magic bullet has become the holy grail for Alzheimer’s researchers. But it’s proving to be an ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

An extended family in that South American country has a devastating genetic variant that triggers early-onset dementia. "They ...

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

A new clinical trial has found that a common brain stimulation technique may help slow down cognitive and functional decline ...

Researchers have developed a tau-targeting vaccine that could help prevent the progression of Alzheimer’s disease by ...

The second U.S. drug shown to slow the progression of early Alzheimer's has arrived in Seattle-area clinics. One of the first ...

Researchers are looking for 200 healthy adults between 65 and 75 who have a close family member with dementia but who do not ...

Can you kindly explain the differences between Alzheimer’ disease, dementia, cognitive impairment and memory loss?Raimi (by SMS) Dementia is a catch-all term and covers all types of brain problems.